CVS Health Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Strong Buy" and an average price target of $116.28. The average 1-year stock price forecast is 34.97% higher than the current stock price, while the lowest is $103 (+19.56%) and the highest is $148 (+71.79%).

Price Target: $116.28 (+34.97%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$103	$116.28	$116	$148
Change	+19.56%	+34.97%	+34.65%	+71.79%

Analyst Ratings

The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	18	18	18	18	18	18
Buy	7	6	6	6	6	7
Hold	3	4	4	4	3	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	28	28	28	28	27	27

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elizabeth Anderson CFA Evercore ISI	Evercore ISI	Buy Maintains $125	Buy	Maintains	$125	+45.10%	Oct 2, 2026
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $123	Buy	Maintains	$123	+42.77%	Sep 15, 2026
Allen Lutz Bank of America Securities	Bank of America Securities	Buy Maintains $1,050 → $120	Buy	Maintains	$1,050 → $120	+39.29%	Sep 15, 2026
Lance Wilkes Bernstein	Bernstein	Buy Reiterates $106	Buy	Reiterates	$106	+23.04%	Sep 9, 2026
Kevin Caliendo UBS	UBS	Buy Reiterates $126 → $118	Buy	Reiterates	$126 → $118	+36.97%	Sep 3, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

417.80B

from 399.83B

4.49%

from 399.83B

Revenue Next Year

429.90B

from 417.80B

2.90%

from 417.80B

EPS This Year

8.04

from 6.75

19.16%

from 6.75

EPS Next Year

8.53

from 8.04

6.03%

from 8.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	290.91B	321.63B	356.62B	370.66B	399.83B	417.80B
Revenue Growth	8.59%	10.56%	10.88%	3.94%	7.87%	4.49%
Gross Profit	50.92B	53.66B	53.28B	49.25B	53.13B	59.62B
Gross Margin	17.50%	16.69%	14.94%	13.29%	13.29%	14.27%
Operating Income	14.16B	15.74B	14.07B	8.02B	10.02B	16.81B
Net Income	8.00B	4.31B	8.34B	4.61B	1.77B	8.87B
EPS	-	-	-	-	6.75	8.04
EPS Growth	-	-	-	-	24.54%	19.16%
Forward PE	12.88	10.67	9.39	7.77	11.54	10.71
Dividend / Share	2.00	2.20	2.42	2.66	2.66	2.66
Dividend Growth	-	10.00%	10.00%	9.92%	-	-0.01%
Free Cash Flow	-	-	-	-	7.81B	9.75B
No. Analysts	-	-	-	-	-	21

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	427.3B
Avg	417.8B
Low	414.2B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	6.9%
Avg	4.5%
Low	3.6%

EPS Forecast

Chart

EPS	2026	2027	2028
High	8.15
Avg	8.04
Low	7.94

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	20.8%
Avg	19.2%
Low	17.6%